APML4 A phase II trial in patients with previously untreated acute promyelocytic leukaemia to evaluate the effects of: (i) adding arsenic trioxide to all-trans retinoic acid and idarubicin for remission induction, and (ii) adding arsenic trioxide to all-trans retinoic acid as consolidation

Name: APML4 A phase II trial in patients with previously untreated acute promyelocytic leukaemia to evaluate the effects of: (i) adding arsenic trioxide to all-trans retinoic acid and idarubicin for remission induction, and (ii) adding arsenic trioxide to all-trans retinoic acid as consolidation
Creator: Health Data Australia Contributor Records
License: 暂无描述

Research Data Australia2024-08-03 收录

下载链接：

https://researchdata.edu.au/apml4-a-phase-acid-consolidation/2538339

下载链接

链接失效反馈

官方服务：

资源简介：

Dataset includes: Data on 200 patients with acute non-lymphocytic leukaemia . High dose Ara-C daunorubicin and VP16-213 (HIDAC-37) versus conventional dose and complete remission in adults. Remission duration/survival. Toxicity of two treatment arms. Prognostic variables. Cytogenetics.

提供机构：

Health Data Australia Contributor Records